Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E-M Muchitsch

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Arzneimittel-Forschung|January 10, 2001
Effects of alpha 1-acid glycoprotein on acute pancreatitis and acute lung injury in ratsE M Muchitsch, K Varadi, L Pichler
Fundamental & Clinical Pharmacology|May 5, 1998
Effects of alpha 1-acid glycoprotein in different rodent models of shockE M Muchitsch, W Auer, L Pichler
Wiener Klinische Wochenschrift|May 5, 1999
[Preclinical investigation of alpha 1-acid glycoprotein (orosomucoid)]L Pichler, E M Muchitsch, H P Schwarz
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1996
In vivo effect of alpha 1-acid glycoprotein on experimentally enhanced capillary permeability in guinea-pig skinE M Muchitsch, W Teschner, Y Linnau, et al.
Arzneimittel-Forschung|January 16, 1998
Studies on the effect of human lys-plasminogen in a rat model of global cerebral ischemiaW Auer, E M Muchitsch, A Philapitsch, et al.
Die Pharmazie|May 4, 2010
Serum-derived immunoglobulins alter amyloid beta transport across a blood-brain barrier in vitro modelV Poetsch, B Bennani-Baiti, W Neuhaus, et al.
Laboratory Animals|May 29, 2010
Optimization, refinement and reduction of murine in vivo experiments to assess therapeutic approaches for haemophilia AB Baumgartner, T Jaki, M J Wolfsegger, et al.
Journal of Thrombosis and Haemostasis : JTH|April 4, 2007
A guide to murine coagulation factor structure, function, assays, and genetic alterationsJ J Emeis, M Jirouskova, E-M Muchitsch, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 3, 2014
The biological efficacy profile of BAX 855, a PEGylated recombinant factor VIII moleculeL A Valentino, L Cong, C Enockson, et al.
Vox Sanguinis|December 22, 2006
A new liquid, intravenous immunoglobulin product (IGIV 10%) highly purified by a state-of-the-art processW Teschner, H A Butterweck, W Auer, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Arzneimittel-Forschung|January 10, 2001
Effects of alpha 1-acid glycoprotein on acute pancreatitis and acute lung injury in ratsE M Muchitsch, K Varadi, L Pichler
Fundamental & Clinical Pharmacology|May 5, 1998
Effects of alpha 1-acid glycoprotein in different rodent models of shockE M Muchitsch, W Auer, L Pichler
Wiener Klinische Wochenschrift|May 5, 1999
[Preclinical investigation of alpha 1-acid glycoprotein (orosomucoid)]L Pichler, E M Muchitsch, H P Schwarz
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1996
In vivo effect of alpha 1-acid glycoprotein on experimentally enhanced capillary permeability in guinea-pig skinE M Muchitsch, W Teschner, Y Linnau, et al.
Arzneimittel-Forschung|January 16, 1998
Studies on the effect of human lys-plasminogen in a rat model of global cerebral ischemiaW Auer, E M Muchitsch, A Philapitsch, et al.
Die Pharmazie|May 4, 2010
Serum-derived immunoglobulins alter amyloid beta transport across a blood-brain barrier in vitro modelV Poetsch, B Bennani-Baiti, W Neuhaus, et al.
Laboratory Animals|May 29, 2010
Optimization, refinement and reduction of murine in vivo experiments to assess therapeutic approaches for haemophilia AB Baumgartner, T Jaki, M J Wolfsegger, et al.
Journal of Thrombosis and Haemostasis : JTH|April 4, 2007
A guide to murine coagulation factor structure, function, assays, and genetic alterationsJ J Emeis, M Jirouskova, E-M Muchitsch, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 3, 2014
The biological efficacy profile of BAX 855, a PEGylated recombinant factor VIII moleculeL A Valentino, L Cong, C Enockson, et al.
Vox Sanguinis|December 22, 2006
A new liquid, intravenous immunoglobulin product (IGIV 10%) highly purified by a state-of-the-art processW Teschner, H A Butterweck, W Auer, et al.
Pageof 2